1-15 of 25
- CME/CE In-Person Event
22nd Annual Women’s Health Annual Visit (WHAV)
November 13, 2026
Pasadena, California
- CME/CE In-Person Event
22nd Annual Women’s Health Annual Visit (WHAV)
December 04, 2026
New York, New York
- CME/CE In-Person Event
22nd Annual Women’s Health Annual Visit (WHAV)
Multiple dates & locations available
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
CME/CEExpert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
Neal Shore, MD, FACS
Sarah Psutka, MD, MS
Karin J. Blakemore, MD
Emilie L. Vander Haar
Karin J. Blakemore, MD
Emilie L. Vander Haar
- advertisement
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
CME/CE Broadcast ReplayOptimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
Kristina Deligiannidis, MD
Jennifer L. Payne, MD
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
MinuteCE®Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
Lee P. Shulman, MD, FACMG, FACOG
Linda Bradley, MD
Strategies to Address Healthcare Disparities in Patients With Endometriosis
MinuteCE®Strategies to Address Healthcare Disparities in Patients With Endometriosis
Linda Bradley, MD
Melissa Simon, MD
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
MinuteCE®Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Lee P. Shulman, MD, FACMG, FACOG
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
The Integral Role of GnRH Antagonists in the Management of Endometriosis
MinuteCE®The Integral Role of GnRH Antagonists in the Management of Endometriosis
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
Pre- and Postoperative Use of GnRH Antagonists
MinuteCE®Pre- and Postoperative Use of GnRH Antagonists
Lee P. Shulman, MD, FACMG, FACOG
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- advertisement
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
MinuteCE®Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
MinuteCE®Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Lee P. Shulman, MD, FACMG, FACOG
Linda Bradley, MD
Samantha Denäe
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
MinuteCE®Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
James A. Simon, MD, CCD, NCMP, IF, FACOG
